Patents Assigned to Breast-Med, Inc.
-
Patent number: 11241296Abstract: An implantable tissue marker incorporates a contrast agent sealed within a chamber in a container formed from a solid material. The contrast agent is selected to produce a change, such as an increase, in signal intensity under magnetic resonance imaging (MRI). An additional contrast agent may also be sealed within the chamber to provide visibility under another imaging modality, such as computed tomographic (CT) imaging or ultrasound imaging.Type: GrantFiled: November 30, 2017Date of Patent: February 8, 2022Assignee: Breast-Med, Inc.Inventors: Patrick Bolan, Michael G. Garwood, Michael T. Nelson, Daniel A. Halpern
-
Patent number: 9861450Abstract: An implantable tissue marker incorporates a contrast agent sealed within a chamber in a container formed from a solid material. The contrast agent is selected to produce a change, such as an increase, in signal intensity under magnetic resonance imaging (MRI). An additional contrast agent may also be sealed within the chamber to provide visibility under another imaging modality, such as computed tomographic (CT) imaging or ultrasound imaging.Type: GrantFiled: December 11, 2015Date of Patent: January 9, 2018Assignee: Breast-Med, Inc.Inventors: Patrick Bolan, Michael G. Garwood, Michael T. Nelson, Daniel A. Halpern
-
Patent number: 9795455Abstract: A radiographic marker containing a sensing medium that initially includes a gas and liquid mixture for producing increased signal intensity in a first imaging modality. The radiographic marker can have a permeable portion allowing the exchange of the gases or liquids of the sensing medium to be changed or exchanged for at least a second fluid in the surrounding tissue to reduce the bubbles or air pockets created by the gas portion of the sensing medium. The change or exchange of gas for the second liquid in the radiographic marker produces a detectable signal intensity of the radiographic marker in a second imaging modality different from the first imaging modality.Type: GrantFiled: August 22, 2014Date of Patent: October 24, 2017Assignee: Breast-Med, Inc.Inventors: Patrick Bolan, Mark C. Gross, Daniel A. Halpern, Michael T. Nelson
-
Patent number: 9241773Abstract: An implantable tissue marker incorporates a contrast agent sealed within a chamber in a container formed from a solid material. The contrast agent is selected to produce a change, such as an increase, in signal intensity under magnetic resonance imaging (MRI). An additional contrast agent may also be sealed within the chamber to provide visibility under another imaging modality, such as computed tomographic (CT) imaging or ultrasound imaging.Type: GrantFiled: March 2, 2015Date of Patent: January 26, 2016Assignee: Breast-Med, Inc.Inventors: Patrick Bolan, Michael G. Garwood, Michael T. Nelson, Daniel A. Halpern
-
Patent number: 8966735Abstract: An implantable tissue marker incorporates a contrast agent scaled within a chamber in a container formed from a solid material. The contrast agent is selected to produce a change, such as an increase, in signal intensity under magnetic resonance imaging (MRI). An additional contrast agent may also be sealed within the chamber to provide visibility under another imaging modality, such as computed tomographic (CT) imaging or ultrasound imaging.Type: GrantFiled: September 10, 2013Date of Patent: March 3, 2015Assignee: Breast-Med, Inc.Inventors: Patrick Bolan, Michael G. Garwood, Michael T. Nelson, Daniel A. Halpern
-
Publication number: 20140187911Abstract: An implantable tissue marker incorporates a contrast agent scaled within a chamber in a container formed from a solid material. The contrast agent is selected to produce a change, such as an increase, in signal intensity under magnetic resonance imaging (MRI). An additional contrast agent may also be sealed within the chamber to provide visibility under another imaging modality, such as computed tomographic (CT) imaging or ultrasound imaging.Type: ApplicationFiled: September 10, 2013Publication date: July 3, 2014Applicant: Breast-Med, Inc.Inventors: Patrick Bolan, Michael G. Garwood, Michael T. Nelson, Daniel A. Halpern
-
Patent number: 8544162Abstract: An implantable tissue marker incorporates a contrast agent sealed within a chamber in a container formed from a solid material. The contrast agent is selected to produce a change, such as an increase, in signal intensity under magnetic resonance imaging (MRI). An additional contrast agent may also be sealed within the chamber to provide visibility under another imaging modality, such as computed tomographic (CT) imaging or ultrasound imaging.Type: GrantFiled: April 19, 2010Date of Patent: October 1, 2013Assignee: Breast-Med, Inc.Inventors: Patrick Bolan, Michael G. Garwood, Michael T. Nelson, Daniel A. Halpern
-
Publication number: 20100287887Abstract: An implantable tissue marker incorporates a contrast agent sealed within a chamber in a container formed from a solid material. The contrast agent is selected to produce a change, such as an increase, in signal intensity under magnetic resonance imaging (MRI). An additional contrast agent may also be sealed within the chamber to provide visibility under another imaging modality, such as computed tomographic (CT) imaging or ultrasound imaging.Type: ApplicationFiled: April 19, 2010Publication date: November 18, 2010Applicant: Breast-Med, Inc.Inventors: Patrick Bolan, Michael G. Garwood, Michael T. Nelson, Daniel A. Halpern
-
Patent number: 7702378Abstract: An implantable tissue marker incorporates a contrast agent sealed within a chamber in a container formed from a solid material. The contrast agent is selected to produce a change, such as an increase, in signal intensity under magnetic resonance imaging (MRI). An additional contrast agent may also be sealed within the chamber to provide visibility under another imaging modality, such as computed tomographic (CT) imaging or ultrasound imaging.Type: GrantFiled: November 17, 2005Date of Patent: April 20, 2010Assignee: Breast-Med, Inc.Inventors: Patrick J. Bolan, Michael Garwood, Michael T. Nelson, Daniel A. Halpern